GET IN TOUCH

End-to-end bioanalytical and bioassay expertise for drug discovery and development.

img

Bioanalytical testing is routinely conducted for compounds in discovery and preclinical and clinical development. For regulatory submissions, GLP-compliant bioanalysis using fully validated methods for blood, urine, and other matrices are performed.

The highly experienced team is capable of offering various bio-analysis including end-to-end development, validation, and sample analysis, method transfer and validation, optimization of commercial kits, and sample analysis. Aragen is equipped with high-end precision instrumentation, assays, and WinNonlin software for conducting kinetic analysis.

Aragen SAS is an experienced GLP-compliant non-clinical testing partner with over 28 years of history in conducting safety assessment studies. From designing a complete study program to running every single test, Aragen can address all your requirements.

  • Toxicokinetic/pharmacokinetic analysis for small and large molecules
  • Method development/Validation/Sample analysis in blood, urine, and other matrices
  • WinNonlin software for analysis and reporting
  • Immunogenicity (Anti-drug antibodies)
  • Biodistribution – vaccines (DNA/RNA), cell therapeutics, gene therapeutics
  • Bioassay
  • Biomarker analysis